Trial intelligence / Profile preview

Patient preference and efficacy of zolmitriptan nasal spray vs sumatriptan RDT in acute migraine

2007-002654-36Phase 4Active

Sponsor
Carl Dahlöf
Start
Aug 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in migraine, migraine with aura and migraine without aura comparing Zolmitriptan nasal spray 5 mg with Sumatriptan RDT 100 mg (2 arms). Started Aug 2007; status: active.

02

Drugs

zolmitriptansumatriptan
03

Conditions

migrainemigraine with auramigraine without aura

Beyond the preview

Go deeper on 2007-002654-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-002654-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call